{
    "SPADE_N_13602": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_13602",
            "Peptide Name": "PR-35 (a proline-arginine-rich peptide with 35 residues, cathelicidin, natural AMPs; pigs, mammals; animals; Pro-rich, PrAMPs)",
            "Source": "pig,Sus scrofa",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "RPPYLPRPRPPPFFPPRLPPRIPPGFPPRFPPRFP",
            "Sequence Length": 35,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram-"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 4154.96,
            "PI": 12.0,
            "Hydrophobicity": -1.03,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Jeon H, Thong LM, Ahn B, Cho HS, Van Chanh Quy L, Yum J, Hong K, Kim JH, Song H, Park C.2019",
                    "Reference": "Gene. 2019 Apr 15;692:88-93. doi: 10.1016/j.gene.2018.12.065.PubMed",
                    "Title": "Copy number variation of PR-39 cathelicidin, and identification of PR-35, a natural variant of PR-39 with reduced mammalian cytotoxicity."
                }
            ],
            "Frequent Amino Acids": "PRF",
            "Absent Amino Acids": "ACDEHKMNOQSTUVW",
            "Basic Residues": 7,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 27,
            "Polar Residues": 8,
            "Positive Residues": 7,
            "Negative Residues": 0,
            "Net Charge": 7,
            "Comments": "Sequence analysis: APD analysis reveals that the sequence of the peptide shows 89.7% similarity toPR-39.  Mol formula: C206H302N56O37; Mol Wt: 4155.03. GRAVY: -1.02.Activity:The antimicrobial activity of chemically synthesized PR-35 was similar to that of PR-39. Active against Gram- bacteria E. coli ATCC 25922 (MIC 3 ug/ml), S. typhimurium ATCC 14028 (MIC 2 ug/ml), P-aeruginosa ATCC 27853 (MIC>32 ug/ml), S-aureus ATCC 25923, and B-cereus ATCC 10876 (MIC >32 ug/ml).Toxicity:  the level of mammalian cell cytotoxicity was lower than the wild type. Updated 7/2021",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_02560",
                    "Similarity": 1.0,
                    "Sequence": "RRRPRPPYLPRPRPPPFFPPRLPPRIPPGFPPRFPPRFP"
                },
                {
                    "SPADE_ID": "SPADE_N_10441",
                    "Similarity": 1.0,
                    "Sequence": "RRRPRPPYLPRPRPPPFFPPRL"
                },
                {
                    "SPADE_ID": "SPADE_N_10442",
                    "Similarity": 1.0,
                    "Sequence": "RRRPRPPYLPRPRPPPFF"
                }
            ]
        }
    }
}